Literature DB >> 25894243

[Diabetes mellitus and dementia].

D Kopf1.   

Abstract

Diabetes mellitus, particularly type 2 diabetes, is a risk factor for dementia and this holds true for incident vascular dementia and Alzheimer's disease. Cerebrovascular complications of diabetes and chronic mild inflammation in insulin resistant states partly account for this increased risk. In addition, cellular resistance to the trophic effects of insulin on neurons and glial cells favor the accumulation of toxic metabolic products, such as amyloid and hyperphosphorylated tau protein (pTau). Weight loss frequently precedes overt cognitive symptoms of Alzheimer's disease. This results in an increased risk of hypoglycemic episodes in stable diabetic patients who are on suitably adjusted doses of oral insulin or insulinotropic antidiabetic drugs. In turn, hypoglycemic episodes may induce further damage in the vulnerable brains of type 2 diabetes patients. Patients with unexplained weight loss, hypoglycemic episodes and subjective memory complaints must be screened for dementia. Once dementia has been diagnosed the goals of diabetes management must be reevaluated as prevention of hypoglycemia becomes more important than tight metabolic control. As weight loss accelerates the rate of cognitive decline, nutritional goals must aim at stabilizing body weight. There is no available evidence on whether drug treatment of diabetes in middle-aged persons can help to prevent dementia; however, physical exercise, mental activity and higher education have preventive effects on the risk of dementia in later life. In addition, nutritional recommendations that are effective in preventing cardiovascular events have also been shown to reduce the risk of dementia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25894243     DOI: 10.1007/s00108-014-3631-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  22 in total

1.  Accelerated weight loss may precede diagnosis in Alzheimer disease.

Authors:  David K Johnson; Consuelo H Wilkins; John C Morris
Journal:  Arch Neurol       Date:  2006-09

Review 2.  Hypertension is a potential risk factor for vascular dementia: systematic review.

Authors:  Sally I Sharp; Dag Aarsland; Sarah Day; Hogne Sønnesyn; Clive Ballard
Journal:  Int J Geriatr Psychiatry       Date:  2010-12-29       Impact factor: 3.485

3.  Insulin has multiple antiamyloidogenic effects on human neuronal cells.

Authors:  Giuseppe Pandini; Vincenza Pace; Agata Copani; Sebastiano Squatrito; Danilo Milardi; Riccardo Vigneri
Journal:  Endocrinology       Date:  2012-12-13       Impact factor: 4.736

4.  Elevated HbA1c is associated with increased risk of incident dementia in primary care patients.

Authors:  Alfredo Ramirez; Steffen Wolfsgruber; Carolin Lange; Hanna Kaduszkiewicz; Siegfried Weyerer; Jochen Werle; Michael Pentzek; Angela Fuchs; Steffi G Riedel-Heller; Tobias Luck; Edelgard Mösch; Horst Bickel; Birgitt Wiese; Jana Prokein; Hans-Helmut König; Christian Brettschneider; Monique M Breteler; Wolfgang Maier; Frank Jessen; Martin Scherer
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  Hyperinsulinemia and cognitive decline in a middle-aged cohort.

Authors:  Sara E Young; Arch G Mainous; Mark Carnemolla
Journal:  Diabetes Care       Date:  2006-12       Impact factor: 19.112

6.  Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort.

Authors:  A M Jacobson; C M Ryan; P A Cleary; B H Waberski; K Weinger; G Musen; W Dahms
Journal:  Diabetologia       Date:  2010-08-29       Impact factor: 10.122

7.  Midlife and late-life obesity and the risk of dementia: cardiovascular health study.

Authors:  Annette L Fitzpatrick; Lewis H Kuller; Oscar L Lopez; Paula Diehr; Ellen S O'Meara; W T Longstreth; José A Luchsinger
Journal:  Arch Neurol       Date:  2009-03

8.  Glucose levels and risk of dementia.

Authors:  Paul K Crane; Rod Walker; Rebecca A Hubbard; Ge Li; David M Nathan; Hui Zheng; Sebastien Haneuse; Suzanne Craft; Thomas J Montine; Steven E Kahn; Wayne McCormick; Susan M McCurry; James D Bowen; Eric B Larson
Journal:  N Engl J Med       Date:  2013-08-08       Impact factor: 91.245

9.  Diabetes, markers of brain pathology and cognitive function: the Age, Gene/Environment Susceptibility-Reykjavik Study.

Authors:  Chengxuan Qiu; Sigurdur Sigurdsson; Qian Zhang; Maria K Jonsdottir; Olafur Kjartansson; Gudny Eiriksdottir; Melissa E Garcia; Tamara B Harris; Mark A van Buchem; Vilmundur Gudnason; Lenore J Launer
Journal:  Ann Neurol       Date:  2014-01       Impact factor: 10.422

10.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.

Authors:  Sam Norton; Fiona E Matthews; Deborah E Barnes; Kristine Yaffe; Carol Brayne
Journal:  Lancet Neurol       Date:  2014-08       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.